Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a new nerve block beat the standard for back surgery pain?

NCT ID NCT07789509

Symptom relief Sponsor: Antalya City Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 27, 2026 · Last updated Aug 28, 2026 · Updated 1 time

Summary

This trial tests two ultrasound-guided nerve blocks for pain after lumbar stabilization surgery. One is the quadro-iliac plane block (QIPB), the other is the erector spinae plane block (ESP). Researchers will compare pain scores, opioid use, and recovery milestones like first walking and hospital stay length. The goal is to see if QIPB offers better pain control and fewer side effects.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Quadro-iliac plane block (QIPB) with bupivacaine, compared to erector spinae plane block (ESP)
What this could lead to
If QIPB works better, it could offer a more effective pain relief method after back surgery, reducing opioid use and speeding up recovery.
What could go wrong
This is a small, early-stage trial, so results may not apply to everyone. Nerve blocks carry risks like bleeding, infection, or temporary leg weakness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Nov 2026

An estimate. Start dates often move.

Expected to finish

Sep 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age between 18 and 80 years * American Society of Anesthesiologists physical status I-III * Scheduled for elective primary lumbar stabilization surgery * Surgery planned under general anesthesia * Ability to understand and use the Numeric Rating Scale * Written informed consent provided Exclusion Criteria: * Refusal to participate * Revision lumbar stabilization surgery * Contraindication to regional anesthesia * Contraindication to peripheral nerve/plane block * Known allergy to local anesthetics or study drugs * Coagulopathy or anticoagulant use incompatible with neuraxial/regional -anesthesia * Infection at the block injection site * Pre-existing neurological deficit involving the lower extremities (unrelated to t-he current spinal pathology) * Peripheral neuropathy * Chronic opioid use * Cognitive impairment or inability to communicate reliably * Severe hepatic or renal failure * Body mass index \> 35 kg/m2 * Pregnancy

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Erector spina plan block are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

agnosia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Erector spina plan block Lumbar stabilization surgery Pain management Quadro-iliac plane block

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.